97 related articles for article (PubMed ID: 9789505)
1. Cost of preventing HIV infection after sexual exposure.
Lindbloom EJ; Stevermer JJ
J Fam Pract; 1998 Oct; 47(4):251-2. PubMed ID: 9789505
[No Abstract] [Full Text] [Related]
2. Chemoprophylaxis after occupational exposure to human immunodeficiency virus in forensic autopsy.
Kibayashi K; NG'walali PM; Tsunenari S
Nihon Hoigaku Zasshi; 1998 Apr; 52(2):163-4. PubMed ID: 9711070
[No Abstract] [Full Text] [Related]
3. [Prophylactic antiretroviral therapy after sexual exposure to HIV: 93 cases].
Timsit FJ; Maillard A; Spindler E; Taquin Y; Deniaud F; Ferchal F; Morel P; Janier M
Ann Dermatol Venereol; 2002; 129(6-7):866-9. PubMed ID: 12218913
[TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
[TBL] [Abstract][Full Text] [Related]
5. [Early treatment of sexual exposure to human immunodeficiency virus].
Derancourt C; Drobacheff C; Verraes S; Beguinot I; Bernard P
Ann Dermatol Venereol; 2000 Jan; 127(1):122-4. PubMed ID: 10717578
[No Abstract] [Full Text] [Related]
6. Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.
Smith D; Berrey MM; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber R; Corey L; Cooper DA
J Infect Dis; 2000 Sep; 182(3):950-4. PubMed ID: 10950796
[TBL] [Abstract][Full Text] [Related]
7. CDC considers 'morning after' therapy for sexual exposure. Centers for Disease Control and Prevention.
AIDS Policy Law; 1997 Jun; 12(12):4. PubMed ID: 11364408
[TBL] [Abstract][Full Text] [Related]
8. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
[TBL] [Abstract][Full Text] [Related]
9. Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).
Boyd MA; Srasuebkul P; Khongphattanayothin M; Ruxrungtham K; Hassink EA; Duncombe CJ; Ubolyam S; Burger DM; Reiss P; Stek M; Lange J; Cooper DA; Phanuphak P
Antivir Ther; 2006; 11(2):223-32. PubMed ID: 16640103
[TBL] [Abstract][Full Text] [Related]
10. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F;
Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923
[TBL] [Abstract][Full Text] [Related]
11. HIV/AIDS following sexual assault in Jamaican children and adolescents: a case for HIV post-exposure prophylaxis.
Steel-Duncan JC; Pierre R; Evans-Gilbert T; Rodriquez B; Christie CD
West Indian Med J; 2004 Oct; 53(5):352-5. PubMed ID: 15675503
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
[TBL] [Abstract][Full Text] [Related]
13. New recommendations on health care worker exposure to HIV.
Woodward J
STEP Perspect; 1996; 8(3):8-10. PubMed ID: 11364268
[TBL] [Abstract][Full Text] [Related]
14. Double protease inhibitor regimens with amprenavir show promise.
AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962
[No Abstract] [Full Text] [Related]
15. HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients.
Quirino T; Niero F; Ricci E; Pusterla L; Carradori S; Gabbuti A; Iemoli E; Landonio S; Faggion I; Bonfanti P;
Antivir Ther; 2000 Sep; 5(3):195-7. PubMed ID: 11075939
[TBL] [Abstract][Full Text] [Related]
16. Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
Jankelevich S; Mueller BU; Mackall CL; Smith S; Zwerski S; Wood LV; Zeichner SL; Serchuck L; Steinberg SM; Nelson RP; Sleasman JW; Nguyen BY; Pizzo PA; Yarchoan R
J Infect Dis; 2001 Apr; 183(7):1116-20. PubMed ID: 11237839
[TBL] [Abstract][Full Text] [Related]
17. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
Clark NM; Dieng Sarr A; Sankalé JL; Kanki PJ; Kazanjian P; Winfield R; Markovitz DM
AIDS; 1998 Dec; 12(18):2506-7. PubMed ID: 9875594
[No Abstract] [Full Text] [Related]
18. HIV postexposure prophylaxis after sexual assault: why is it so hard to accomplish?
Cohen MS
Sex Transm Dis; 2008 Dec; 35(12):979-80. PubMed ID: 18955917
[No Abstract] [Full Text] [Related]
19. Study shows three drugs better than two.
AIDS Alert; 1997 Apr; 12(4):39. PubMed ID: 11364145
[TBL] [Abstract][Full Text] [Related]
20. [Post-exposure prophylaxis in Zambia; the experiences of a tropical disease specialist following a cut accidentally incurred while operating on an HIV positive patient].
Stekelenburg J
Ned Tijdschr Geneeskd; 2002 Mar; 146(13):625-8. PubMed ID: 11957385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
